New Prognostic Indicator For Patients With IPF, University of Calgary Study

EurekAlert! -- There may be a new way to predict mortality in patients with idiopathic pulmonary fibrosis (IPF), a devastating disease that slowly petrifies the lungs. Most patients live only three years after diagnosis on average; however, some remain stable for many years, while for others, the disease progresses more rapidly.

MORE ON THIS TOPIC